These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 26385482

  • 1. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
    Dai CH, Li J, Chen P, Jiang HG, Wu M, Chen YC.
    J Biomed Sci; 2015 Sep 18; 22(1):77. PubMed ID: 26385482
    [Abstract] [Full Text] [Related]

  • 2. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P, Li J, Jiang HG, Lan T, Chen YC.
    Tumour Biol; 2015 May 18; 36(5):3591-9. PubMed ID: 25542235
    [Abstract] [Full Text] [Related]

  • 3. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.
    Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M.
    PLoS One; 2012 May 18; 7(8):e44254. PubMed ID: 22952942
    [Abstract] [Full Text] [Related]

  • 4. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.
    He M, Sun HG, Hao JY, Li YL, Yu JK, Yan YY, Zhao L, Li N, Wang Y, Bai XF, Yu ZJ, Zheng ZH, Mi XY, Wang EH, Wei MJ.
    Oncol Rep; 2013 May 18; 29(5):1721-9. PubMed ID: 23440494
    [Abstract] [Full Text] [Related]

  • 5. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
    Yao C, Du W, Chen H, Xiao S, Huang L, Chen F.
    Leuk Lymphoma; 2015 Mar 18; 56(3):755-62. PubMed ID: 24996439
    [Abstract] [Full Text] [Related]

  • 6. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
    Snyder ER, Ricker JL, Chen Z, Waes CV.
    Cancer Lett; 2007 Jan 08; 245(1-2):75-80. PubMed ID: 16466850
    [Abstract] [Full Text] [Related]

  • 7. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
    Yao C, Du W, Chen H, Xiao S, Huang L, Chen FP.
    Mol Med Rep; 2015 Jun 08; 11(6):4605-10. PubMed ID: 25647473
    [Abstract] [Full Text] [Related]

  • 8. Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin.
    Burkitt K, Ljungman M.
    Mol Cancer; 2008 Mar 06; 7():24. PubMed ID: 18325101
    [Abstract] [Full Text] [Related]

  • 9. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
    Zhao L, Li N, Yu JK, Tang HT, Li YL, He M, Yu ZJ, Bai XF, Zheng ZH, Wang EH, Wei MJ.
    Braz J Med Biol Res; 2014 Jan 06; 47(1):24-34. PubMed ID: 24345874
    [Abstract] [Full Text] [Related]

  • 10. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
    Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD.
    Nat Med; 2003 May 06; 9(5):568-74. PubMed ID: 12692539
    [Abstract] [Full Text] [Related]

  • 11. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
    Zhao L, Li Y, He M, Song Z, Lin S, Yu Z, Bai X, Wang E, Wei M.
    Int J Oncol; 2014 Jul 06; 45(1):129-38. PubMed ID: 24789349
    [Abstract] [Full Text] [Related]

  • 12. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD.
    Exp Hematol; 2001 Dec 06; 29(12):1448-55. PubMed ID: 11750104
    [Abstract] [Full Text] [Related]

  • 13. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
    Chen P, Li J, Chen YC, Qian H, Chen YJ, Su JY, Wu M, Lan T.
    Cell Oncol (Dordr); 2016 Dec 06; 39(6):511-522. PubMed ID: 27473273
    [Abstract] [Full Text] [Related]

  • 14. Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.
    Zhang J, Wang X, Lin CJ, Couch FJ, Fei P.
    Cancer Biol Ther; 2006 Dec 06; 5(12):1632-6. PubMed ID: 17106252
    [Abstract] [Full Text] [Related]

  • 15. The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.
    D'Andrea AD.
    Cell Cycle; 2003 Dec 06; 2(4):290-2. PubMed ID: 12851475
    [Abstract] [Full Text] [Related]

  • 16. BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.
    Nakashima S, Kobayashi S, Nagano H, Tomokuni A, Tomimaru Y, Asaoka T, Hama N, Wada H, Kawamoto K, Marubashi S, Eguchi H, Doki Y, Mori M.
    Cancer Sci; 2015 May 06; 106(5):584-91. PubMed ID: 25736055
    [Abstract] [Full Text] [Related]

  • 17. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
    Jacquemont C, Simon JA, D'Andrea AD, Taniguchi T.
    Mol Cancer; 2012 Apr 26; 11():26. PubMed ID: 22537224
    [Abstract] [Full Text] [Related]

  • 18. Drosophila homologs of FANCD2 and FANCL function in DNA repair.
    Marek LR, Bale AE.
    DNA Repair (Amst); 2006 Nov 08; 5(11):1317-26. PubMed ID: 16860002
    [Abstract] [Full Text] [Related]

  • 19. RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair network.
    Geng L, Huntoon CJ, Karnitz LM.
    J Cell Biol; 2010 Oct 18; 191(2):249-57. PubMed ID: 20937699
    [Abstract] [Full Text] [Related]

  • 20. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X, Fan XF, Li Q, Liu S, Wu DY, Wang SY, Shi Y, Dong M.
    Oncol Rep; 2019 Mar 18; 41(3):1875-1882. PubMed ID: 30628719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.